The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma

References

• Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgki's Lymphoma Classification Project. J Clin Oncol 1998;16:2780–2795.
   PubMed Web of Science ®Google Scholar
• Groves FD, Linet MS, Travis LB, . Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240–1251.
   PubMed Web of Science ®Google Scholar
• Chiu BC, Weisenburger DD. An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 2003;4:161–168.
   PubMedGoogle Scholar
• Kornacker M, Stumm J, Pott C, . Characteristics of relapse after autologous stem cell transplantation for follicular lymphoma: a long-term follow-up. Ann Oncol 2009;20:722–728.
   PubMed Web of Science ®Google Scholar
• Rohatiner AZ, Nadler L, Davies AJ, . Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol 2007;25:2554–2559.
   PubMed Web of Science ®Google Scholar
• Montoto S, Canals C, Rohatiner AZ, . Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia 2007;21:2324–2331.
   PubMed Web of Science ®Google Scholar
• Vose JM, Bierman PJ, Loberiza FR, . Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index. Biol Blood Marrow Transplant 2008;14:36–42.
   PubMed Web of Science ®Google Scholar
• Witzens-Harig M, Dreger P. Autologous transplant of follicular lymphoma in the era of rituximab. Leuk Lymphoma 2010; 51:967–974.
   PubMed Web of Science ®Google Scholar
• Pettengell R, Donatti C, Hoskin P, . The impact of follicular lymphoma on health-related quality of life. Ann Oncol 2008;19: 570–576.
   PubMed Web of Science ®Google Scholar
• Smith SK, Crespi CM, Petersen L, . The impact of cancer and quality of life for post-treatment non-Hodgkin lymphoma survivors. Psychooncology 2010;19:1259–1267.
   PubMed Web of Science ®Google Scholar
• Smith SK, Zimmerman S, Williams CS, . Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer 2009;115:3312–3323.
   PubMed Web of Science ®Google Scholar
• Czuczman M, Straus D, Gribben J, . Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas. Leuk Lymphoma 2010.
   Web of Science ®Google Scholar
• Ruffer JU, Flechtner H, Tralls P, . Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 2003;39:2179–2186.
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Fossa SD, Oldervoll L, . Fatigue in long-term Hodgkin's disease survivors: a follow-up study. J Clin Oncol 2005;23:6587–6595.
   PubMed Web of Science ®Google Scholar
• Konig HH, Bernert S, Angermeyer MC. [Health status of the German population: results of a representative survey using the EuroQol questionnaire]. Gesundheitswesen 2005;67: 173–182.
   PubMed Web of Science ®Google Scholar
• Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345–1351.
   PubMed Web of Science ®Google Scholar
• Fox-Rushby J, Selai C. What concepts does the EQ-5D measure? Intentions and interpretations. Brooks R, Rabin R, de Charro F, editors. The measurement and valuation of health status using EQ-5D: a European perspective: evidence from the EuroQol BIO MED Research Programme. Rotterdam: Kluwer Academic Publishers; 2003. pp 167–168.
   Google Scholar
• Fayers P, Bottomley A. Quality of life research within the EORTC—the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002;38(Suppl. 4): S125–S133.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–376.
   PubMed Web of Science ®Google Scholar
• Fayers P, Aaronson N, Bjordal K, .; on behalf of the EORTC Quality of Life Group. EORTC QLQ-C30 Scoring Manual. 3rd. Brussels: EORTC; 2001.
   Google Scholar
• Kornacker M, Stumm J, Pott C, . Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up. Ann Oncol 2009;20:722–728.
   PubMed Web of Science ®Google Scholar
• Frick E, Borasio GD, Zehentner H, . Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psychooncology 2004;13:116–124.
   PubMed Web of Science ®Google Scholar
• Hacker ED, Ferrans CE. Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 2003; 26:312–322.
   PubMed Web of Science ®Google Scholar
• Wettergren L, Sprangers M, Bjorkholm M, . Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology 2008;17:338–346.
   PubMed Web of Science ®Google Scholar
• Jo JC, Kang BW, Jang G, . BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity. Ann.Hematol 2008;87:43–48.
   PubMed Web of Science ®Google Scholar
• Puig N, de la Rubia J, Remigia MJ, . Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation. Leuk Lymphoma 2006;47: 1488–1494.
   PubMed Web of Science ®Google Scholar
• Chap L, Shpiner R, Levine M, . Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. Bone Marrow Transplant 1997;20:1063–1067.
   PubMed Web of Science ®Google Scholar
• Johnston LJ, Stockerl-Goldstein KE, Hu WW, . Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. Biol.Blood Marrow Transplant 2000;6:555–562.
   PubMed Web of Science ®Google Scholar
• Conner-Spady BL, Cumming C, Nabholtz JM, . A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation. Bone Marrow Transplant 2005;36:251–259.
   PubMed Web of Science ®Google Scholar
• Peppercorn J, Herndon J, Kornblith AB, . Quality of life among patients with stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. Cancer 2005; 104:1580–1589.
   PubMed Web of Science ®Google Scholar
• Gulbrandsen N, Wisloff F, Brinch L, . Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 2001;18:65–77.
   PubMed Web of Science ®Google Scholar
• Carlson LE, Koski T, Gluck S. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer. Bone Marrow Transplant 2001;27:989–998.
   PubMed Web of Science ®Google Scholar
• Hensel M, Egerer G, Schneeweiss A, . Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol 2002;13:209–217.
   PubMed Web of Science ®Google Scholar
• Wettergren L, Bjorkholm M, Axdorph U, . Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004;13:1369–1379.
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Oldervoll L, Fossa SD, . Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 2006;42:327–333.
   PubMed Web of Science ®Google Scholar
• Greil R, Holzner B, Kemmler G, . Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 1999;35: 698–706.
   PubMed Web of Science ®Google Scholar
• Norum J, Wist EA. Quality of life in survivors of Hodgkin's disease. Qual Life Res 1996;5:367–374.
   PubMed Web of Science ®Google Scholar